News Focus
News Focus
icon url

Whalatane

11/06/23 12:05 AM

#417718 RE: Laurent Maldague #417717

Path of least resistance to FDA approval is a Clarity AD / Trailblazer-Alz-2 type P3 trial ( thx for noting those previously ) .
Since Vascepa has a well documented safety record as an approved drug ...trial should enroll very quickly ....PET scans make this a lot more patient friendly .
Kiwi
icon url

Number sleven

11/06/23 8:52 AM

#417726 RE: Laurent Maldague #417717

Laurent,
https://www.statnews.com/2018/03/05/alzheimers-disease-drugs-fda/
This is a good quick read. It explains the the recent shift in guidelines.
Sleven,